• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Antimicrobial formulary management: a case study in a teaching hospital.

作者信息

Wright D B

机构信息

Department of Pharmacy Services, Henry Ford Hospital, Detroit, Michigan 48202.

出版信息

Pharmacotherapy. 1991;11(1 ( Pt 2)):27S-31S.

PMID:2011570
Abstract

The role of the formulary system for effective cost containment is becoming increasingly important. With antimicrobial agents taking up a large proportion of most pharmaceutical budgets, this group of agents is an obvious target for cost reduction. The responsible interchange of selected antimicrobial agents offers a promising method to achieve this goal. The Pharmacy and Therapeutics Committee at Henry Ford Hospital implemented the formulary replacement of cefoxitin with cefotetan on a cost basis after the agents were evaluated and considered to be therapeutically equivalent. Drug usage guidelines were developed to implement this change. Educational materials were distributed to the medical staff, and lectures on the appropriate use of cefotetan were given to the house staff. On implementation, all orders written for cefoxitin were automatically changed to cefotetan in the appropriate dosage. After the first 12 months of cefotetan usage no unanticipated problems with treatment failures or adverse effects were noted. Based on analysis of cefotetan use for the first year, a savings of +4F229,811 was achieved with this interchange.

摘要

相似文献

1
Antimicrobial formulary management: a case study in a teaching hospital.
Pharmacotherapy. 1991;11(1 ( Pt 2)):27S-31S.
2
Formulary conversion of cefoxitin usage to cefotetan: experience at a large teaching hospital.头孢西丁使用转换为头孢替坦的处方集管理:一家大型教学医院的经验
DICP. 1989 Dec;23(12):1024-30. doi: 10.1177/106002808902301216.
3
Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents.
Am J Hosp Pharm. 1990 Mar;47(3):585-91.
4
Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.通过具有成本效益的第一代头孢菌素处方集改变医生的处方习惯。
Hosp Pharm. 1989 Jan;24(1):33-8.
5
Antimicrobial formulary management: meeting the challenge in a health maintenance organization.抗菌药物处方集管理:在健康维护组织中应对挑战
Pharmacotherapy. 1991;11(1 ( Pt 2)):32S-35S.
6
Multidisciplinary approach to cost reduction of C-section prophylaxis.降低剖宫产预防成本的多学科方法。
Hosp Formul. 1990 Apr;25(4):446-8, 450.
7
Automatic interchange policy for cefotetan and cefoxitin.头孢替坦和头孢西丁的自动更换策略。
Am J Hosp Pharm. 1988 Sep;45(9):1864.
8
Formulary evaluation of second-generation cephamycin derivatives using decision analysis.使用决策分析对第二代头孢霉素衍生物进行处方集评估。
Am J Hosp Pharm. 1991 Oct;48(10):2146-50.
9
Promoting the cost-effective utilization of cefoxitin with a drug use education program.
Hosp Formul. 1987 Mar;22(3):299-306.
10
An inside look at the UCLA P&T committee: how does it influence prescribing practices?
Hosp Formul. 1986 Feb;21(2):214-7.

引用本文的文献

1
Sequential antibiotic therapy: Effective cost management and patient care.序贯抗生素治疗:有效的成本管理与患者护理。
Can J Infect Dis. 1995 Nov;6(6):306-15. doi: 10.1155/1995/165848.
2
A multidisciplinary hospital-based antimicrobial use program: Impact on hospital pharmacy expenditures and drug use.一项基于医院的多学科抗菌药物使用计划:对医院药房支出和药物使用的影响。
Can J Infect Dis. 1996 Mar;7(2):104-9. doi: 10.1155/1996/685704.
3
Trospectomycin in acute pelvic inflammatory disease: a preliminary report.曲古霉素治疗急性盆腔炎:初步报告。
Infect Dis Obstet Gynecol. 1997;5(3):215-8. doi: 10.1155/S1064744997000355.
4
Single-blind, prospective, randomized study of cefmetazole and cefoxitin in the treatment of postcesarean endometritis.头孢美唑与头孢西丁治疗剖宫产术后子宫内膜炎的单盲、前瞻性、随机研究
Infect Dis Obstet Gynecol. 1995;3(1):28-33. doi: 10.1155/S1064744995000263.
5
Therapeutic interchange as a cost-containment measure {editorial}.作为一种成本控制措施的治疗性药物互换{社论}
Pharmacoeconomics. 1992 Nov;2(5):347-51. doi: 10.2165/00019053-199202050-00001.
6
Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.机构处方集:药物经济学分析与处方集决策的相关性。
Pharmacoeconomics. 1992 Apr;1(4):265-81. doi: 10.2165/00019053-199201040-00004.